22.626 articles found

[Severe kyphosis and esophagus hiatal hernia affected in the levodopa absorption of a patient with Parkinson's disease].

Chihara N, Yamamoto T, Lin Y, Tsukamoto T, Ogawa M, Murata M.

Rinsho Shinkeigaku · 2009-08-01

DOI: 10.5692/clinicalneurol.49.493PMID: 19827600

Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer's disease.

Reddy PH.

CNS Spectr · 2009-08-01

DOI: 10.1017/s1092852900024901PMID: 19890241

Fluorinated molecules in the diagnosis and treatment of neurodegenerative diseases.

Gaye B, Adejare A.

Future Med Chem · 2009-08-01

DOI: 10.4155/fmc.09.85PMID: 21426082

Cripto blocking molecules and therapeutic uses thereof

MINCHIOTTI GABRIELLA, RUVO MENOTTI, DE FALCO SANDRO, MARASCO DANIELA, LONARDO ENZA, PARISH CLARE, ARENAS ERNEST.

· 2009-07-31

Cells therapy for Parkinson's disease--so close and so far away.

Ren Z, Zhang Y.

Sci China C Life Sci · 2009-07-30

DOI: 10.1007/s11427-009-0090-8PMID: 19641865

Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo 200) in the treatment of Parkinson's disease: a case series.

Sethi KD, Hauser RA, Isaacson SH, McClain T.

Cases J · 2009-07-30

DOI: 10.4076/1757-1626-2-7134PMID: 19829918

Effect of the metabotropic glutamate antagonist MPEP on striatal expression of the Homer family proteins in levodopa-treated hemiparkinsonian rats.

Jiménez A, Bonastre M, Aguilar E, Marin C.

Psychopharmacology (Berl) · 2009-07-28

DOI: 10.1007/s00213-009-1600-xPMID: 19636538

TISSUE KALLIKREIN FOR THE TREATMENT OF PARKINSON'S DISEASE

CHARLES MATTHEW L, WILLIAMS MARK.

· 2009-07-24

Use of a nicotinic receptor agonist in the treatment of dyskinesias associated with dopaminergic agent therapy

QUIK MARYKA, MONTE DONATO DI, LANGSTON J WILLIAM.

· 2009-07-24

TISSUE KALLIKREIN FOR THE TREATMENT OF PARKINSON'S DISEASE

CHARLES MATTHEW L, WILLIAMS MARK.

· 2009-07-24

TISSUE KALLIKREIN FOR THE TREATMENT OF PARKINSON'S DISEASE

CHARLES MATTHEW L, WILLIAMS MARK.

· 2009-07-24

Serum uric acid levels in patients with Parkinson's disease: their relationship to treatment and disease duration.

Andreadou E, Nikolaou C, Gournaras F, Rentzos M, Boufidou F, Tsoutsou A, Zournas C, Zissimopoulos V, Vassilopoulos D.

Clin Neurol Neurosurg · 2009-07-24

DOI: 10.1016/j.clineuro.2009.06.012PMID: 19632030